(Q38439626)

English

Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study.

scientific article published on 10 December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Yoshikazu Kinoshita

6

object named as

Yoshikazu Kinoshita

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

9

object named as

Tsutomu Chiba

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Kentaro Sugano

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jaw-Town Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Shinya Goto

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Yasushi Okada

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Hiroto Miwa

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Chern-En Chiang

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Masatsugu Hori

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Yasushi Fukushima

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Hyun-Soo Kim

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Chi-Yang Chang

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Masataka Date

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

LAVENDER Study Group

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

0 references

publication date

10 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

63

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1061-1068

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Prophylactic aspirin and risk of peptic ulcer bleeding

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Investigation of gastric and duodenal mucosal defects caused by low-dose aspirin in patients with ischemic heart disease

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Impact of gastrointestinal problems on adherence to low-dose acetylsalicylic Acid: a quantitative study in patients with cardiovascular risk

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Low-dose aspirin therapy for cardiovascular prevention: quantification and consequences of poor compliance or discontinuation

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Two-sided confidence intervals for the single proportion: comparison of seven methods

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Biphasic effects of H. pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Systematic review and meta-analysis: enhanced efficacy of proton-pump inhibitor therapy for peptic ulcer bleeding in Asia--a post hoc analysis from the Cochrane Collaboration

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-304722

21 January 2018

Identifiers

10.1136/GUTJNL-2013-304722

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24326741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38439626&oldid=1721954420"